vers la météo de la validation par utilisateur

Ingenuity438

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 69 - PMID ?

Type 2 diabetes in humans is associated with mutant __SP__ __NODE__ protein ( P12A ) .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
      +--------SUBJ:V_PASS-N-------+---------COMP:V_PASS-N(with)--------+              
      +-------OBJ:V-N-------+      |             +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |             |      +-MOD_ATT:N-ADJ-+              
   +OB+     +COMP:N-N(i+    |      |             |      |       +MOD_ATT+--APPOS-+     
   |  |     |          |    |      |             |      |       |       |        |     
 Type 2 diabetes in humans is associated with mutant __SP__ __NODE__ protein ( P12A ) .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,protein)
MOD_ATT:N-ADJ (protein,mutant)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,P12A)
Analyse 1 
      +--------SUBJ:V_PASS-N-------+                                                   
      +-------OBJ:V-N-------+      |             +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |             |      +-MOD_ATT:N-ADJ-+              
   +OB+     +COMP:N-N(i+    |      |             |      |       +MOD_ATT+--APPOS-+     
   |  |     |          |    |      |             |      |       |       |        |     
 Type 2 diabetes in humans is associated with mutant __SP__ __NODE__ protein ( P12A ) .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
MOD_ATT:N-ADJ (protein,mutant)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,P12A)
Analyse 2 
      +--------------------------COMP:N-N(with)-------------------------+              
      +--------SUBJ:V_PASS-N-------+                                    |              
      +-------OBJ:V-N-------+      |             +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |             |      +-MOD_ATT:N-ADJ-+              
   +OB+     +COMP:N-N(i+    |      |             |      |       +MOD_ATT+--APPOS-+     
   |  |     |          |    |      |             |      |       |       |        |     
 Type 2 diabetes in humans is associated with mutant __SP__ __NODE__ protein ( P12A ) .
OBJ:V-N (type,2)
COMP:N-N(with) (2,protein)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
MOD_ATT:N-ADJ (protein,mutant)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,P12A)
Analyse 3 
      +--------SUBJ:V_PASS-N-------+                                                   
      +-------OBJ:V-N-------+      |       +-----------OBJ:V-N----------+              
      |     +----SUBJ:V-N---+      +-COMP:V_PASS-N(with)+               |              
   +OB+     +COMP:N-N(i+    |      |       |     +MOD_AT+       +MOD_ATT+--APPOS-+     
   |  |     |          |    |      |       |     |      |       |       |        |     
 Type 2 diabetes in humans is associated with mutant __SP__ __NODE__ protein ( P12A ) .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,P12A)
Analyse 4 
      +--------SUBJ:V_PASS-N-------+-----COMP:V_PASS-N(with)----+                      
      +-------OBJ:V-N-------+      |       +-----------OBJ:V-N----------+              
      |     +----SUBJ:V-N---+      |       |     +-MOD_ATT:N-ADJ+       |              
   +OB+     +COMP:N-N(i+    |      |       |     |      +MOD_ATT+       +--APPOS-+     
   |  |     |          |    |      |       |     |      |       |       |        |     
 Type 2 diabetes in humans is associated with mutant __SP__ __NODE__ protein ( P12A ) .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,__NODE__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (protein,P12A)
Analyse 5 
      +--------SUBJ:V_PASS-N-------+                                                   
      +-------OBJ:V-N-------+      |                                                   
      |     +----SUBJ:V-N---+      |       +-----------OBJ:V-N----------+              
   +OB+     +COMP:N-N(i+    |      |       |     +MOD_AT+       +MOD_ATT+--APPOS-+     
   |  |     |          |    |      |       |     |      |       |       |        |     
 Type 2 diabetes in humans is associated with mutant __SP__ __NODE__ protein ( P12A ) .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,mutant)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,P12A)
Analyse 6 
      +--------SUBJ:V_PASS-N-------+                                                   
      +-------OBJ:V-N-------+      |       +-----------OBJ:V-N----------+              
      |     +----SUBJ:V-N---+      |       |     +-MOD_ATT:N-ADJ+       |              
   +OB+     +COMP:N-N(i+    |      |       |     |      +MOD_ATT+       +--APPOS-+     
   |  |     |          |    |      |       |     |      |       |       |        |     
 Type 2 diabetes in humans is associated with mutant __SP__ __NODE__ protein ( P12A ) .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__NODE__,mutant)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (protein,P12A)